DVAX insider buying and SEC filings, explained
Dynavax Technologies Corp. · CIK 1029142
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$2.2M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jan 15, 2026 | Planned (10b5-1) | David F Novack (President / COO) sold 114,000 shares at about $15.64 ($1.8M), marked as a 10b5-1 plan trade. Holdings down 64% to 63,344 shares. | SEC filing Filed Jan 20, 2026 |
| Dec 24, 2025 | Planned (10b5-1) | David F Novack (President / COO) sold 30,000 shares at $15.49 ($465K), marked as a 10b5-1 plan trade. Holdings down 21% to 111,451 shares. | SEC filing Filed Dec 29, 2025 |
19 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow DVAX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.